Category: Giulio Maria Pasinetti

Mount Sinai researchers find new Alzheimer's disease treatment promising

July 12, 2009

(New York, NY -- July 12, 2009) -- Researchers at Mount Sinai School of Medicine have found that a compound called NIC5-15, might be a safe and effective treatment to stabilize cognitive performance in patients with mild to moderate Alzheimer's disease. The two investigators, Giulio Maria Pasinetti, M.D., Ph.D.

Mount Sinai researchers discover novel mechanisms that might causally link type-2 diabetes to Alzheimer's disease

April 10, 2009

A recent study by Mount Sinai faculty suggests that a gene associated with onset of type-2 diabetes also decreases in Alzheimer's disease dementia cases. The research, led by Dr.

Reduced calorie and carbohydrate diet slows progression of Alzheimer's disease in mouse model

January 12, 2005

Researchers found that a low carbohydrate diet that reduced total caloric intake by 30% prevented the development of a fundamental feature of Alzheimer's disease (AD) in a strain of mice genetically engineered to develop the disease. The diet eliminated amyloid plaque development, which is the underlying pathology in AD. The study, published in the January issue of The FASEB Journal, is the first to demonstrate that a change in diet can slow and possibly prevent Alzheimer's diseases.